Menu UF Health Home Menu
 

Publications

Publications Contributed To

  1. Xiao W, Conlon T, Hughes J, Agbandje-McKenna M, Ferkol T, Flotte T, Muzyczka N. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J Virol 2000 Sep;74(18):8635-47.
  2. Owen R 4th, Mandel RJ, Ammini CV, Conlon TJ, Kerr DS, Stacpoole PW, Flotte TR. Gene therapy for pyruvate dehydrogenase E1alpha deficiency using recombinant adeno-associated virus 2 (rAAV2) vectors. Mol Ther 2002 Sep;6(3):394-9.
  3. Loiler SA, Conlon TJ, Song S, Tang Q, Warrington KH, Agarwal A, Kapturczak M, Li C, Ricordi C, Atkinson MA, Muzyczka N, Flotte TR. Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver. Gene Ther. 2003 Sep;10(18):1551-8.
  4. Conlon TJ, Flotte TR. Recombinant adeno-associated virus vectors for gene therapy. Expert Opin Biol Ther. 2004 Jul;4(7):1093-101.
  5. Virella-Lowell I, Zusman B, Foust K, Loiler S, Conlon T, Song S, Chesnut KA, Ferkol T, Flotte TR. Enhancing rAAV vector expression in the lung. J Gene Med. 2005 Apr 19.
  6. Conlon TJ, Cossette T., Erger K, Choi YK, Clarke T, Scott-Jorgensen M, Song S, Campbell-Thompson M., Crawford J, Flotte TR. Efficient hepatic delivery and expression from a recombinant adeno-associated 8 pseudotyped alpha1-antitrypsin vector. Mol Ther. 2005 Nov;12(5):867-75.
  7. Conlon TJ, Walter G, Owen R, Cossette T, Erger K, Gutierrez G, Goetzman E, Matern D, Vockley J, Flotte TR. Systemic correction of a fatty acid oxidation defect by intramuscular injection of a recombinant adeno-associated virus vector. Hum Gene Ther. 2006 Jan;17(1):71-80.
  8. Brantly ML, Spencer LT, Humphries M, Conlon TJ, Spencer CT, Poirier A, Garlington W, Baker D, Song S, Berns KI, Muzyczka N, Snyder RO, Byrne BJ, Flotte TR. Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults. Hum Gene Ther. 2006 Dec;17(12):1177-86; PMID: 17115945.
  9. Pacak CA, Mah CS, Thattaliyath BD, Conlon TJ, Lewis MA, Cloutier DE, Zolotukhin I, Tarantal AF, Byrne BJ. Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ Res. 2006 Aug 18;99(4):e3-9. Epub 2006 Jul 27.
  10. Jacobson SG, Boye SL, Aleman TS, Conlon TJ, Zeiss CJ, Roman AJ, Cideciyan AV, Schwartz SB, Komaromy AM, Doobrajh M, Cheung AY, Sumaroka A, Pearce-Kelling SE, Aguirre GD, Kaushal S, Maguire AM, Flotte TR, Hauswirth WW. Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis. Hum Gene Ther. 2006 Aug;17(8):845-58; PMID: 16942444.
  11. Jacobson SG, Acland GM, Aguirre GD, Aleman TS, Schwartz SB, Cideciyan AV, Zeiss CJ, Komaromy AM, Kaushal S, Roman AJ, Windsor EA, Sumaroka A, Pearce-Kelling SE, Conlon TJ, Chiodo VA, Boye SL, Flotte TR, Maguire AM, Bennett J, Hauswirth WW. Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection. Mol Ther. 2006 Jun;13(6):1074-84. Epub 2006 Apr 27; PMID: 16644289.
  12. Flotte TR, Conlon TJ, Poirier A, Campbell-Thompson M, Byrne BJ. Preclinical characterization of a recombinant adeno-associated virus type 1-pseudotyped vector demonstrates dose-dependent injection site inflammation and dissemination of vector genomes to distant sites. Hum Gene Ther. 2007, Mar;18(3):245-56; PMID: 17376008.
  13. Lourdes M. Andino, Thomas J. Conlon, Stacy L. Porvasnik, Sanford L. Boye, William W. Hauswirth, Alfred S. Lewin. Rapid, widespread transduction of the murine myocardium using self-complementary Adeno-associated virus. Genetic Vaccines and Therapy. 10 December 2007.
  14. Erger KE, Conlon TJ, Leal NA, Zori R, Bobik TA, Flotte TR. In vivo expression of human ATP:cob(I)alamin adenosyltransferase (ATR) using recombinant adeno-associated virus (rAAV) serotypes 2 and 8. J Gene Med. 2007 Jun;9(6):462-9.
  15. Beattie SG, Goetzman E, Conlon T, Germain S, Walter G, Campbell-Thompson M, Matern D, Vockley J, Flotte TR. Biochemical correction of short-chain acyl-coenzyme A dehydrogenase deficiency after portal vein injection of rAAV8-SCAD. Hum Gene Ther. 2008 Jun;19(6):579-88.
  16. Flotte TR, Goetzmann J, Caridi J, Paolillo J, Conlon TJ, Potter M, Mueller C, Byrne BJ. Apparently nonspecific enzyme elevations after portal vein delivery of recombinant adeno-associated virus serotype 2 vector in hepatitis C virus-infected chimpanzees. Hum Gene Ther. 2008 Jul;19(7):681-9; PMID: 18588426.
  17. Beattie SG, Goetzman E, Tang Q, Conlon T, Campbell-Thompson M, Matern D, Vockley J, Flotte TR. Recombinant adeno-associated virus-mediated gene delivery of long chain acyl coenzyme A dehydrogenase (LCAD) into LCAD-deficient mice. J Gene Med. 2008 Oct;10(10):1113-23.
  18. Hauswirth WW, Aleman TS, Kaushal S, Cideciyan AV, Schwartz SB, Wang L, Conlon TJ, Boye SL, Flotte TR, Byrne BJ, Jacobson SG. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther. 2008 Oct;19(10):979-90; PMID: 18774912.
  19. Pacak CA, Conlon T, Mah CS, Byrne BJ. Relative persistence of AAV serotype 1 vector genomes in dystrophic muscle. Genet Vaccines Ther. 2008 Oct 15;6:14.
  20. Cideciyan AV, Hauswirth WW, Aleman TS, Kaushal S, Schwartz SB, Boye SL, Windsor EA, Conlon TJ, Sumaroka A, Roman AJ, Byrne BJ, Jacobson SG. Vision 1 year after gene therapy for Leber’s congenital amaurosis. N Engl J Med. 2009 Aug 13;361(7):725-7; PMID: 19675341.
  21. Brantly ML, Chulay JD, Wang L, Mueller C, Humphries M, Spencer LT, Rouhani F, Conlon TJ, Calcedo R, Betts MR, Spencer C, Byrne BJ, Wilson JM, Flotte TR. Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy. Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16363-8. PMCID:PMC2752529
  22. Jerry R. Mendell, Louise R. Rodino-Klapac, Xiomara Rosales-Quintero, Janaiah Kota, Brian D. Coley, Gloria Galloway, Josepha M. Craenen, Sarah Lewis, Vinod Malik, Christopher Shilling, Barry J. Byrne, Thomas Conlon, Katherine J Campbell, William G. Bremer, Laurence Viollet, Christopher M. Walker, Zarife Sahenk, Ph.D, K. Reed Clark. LGMD 2D gene therapy restores alpha-sarcoglycan and associated proteins. Ann Neurol. 2009 Sep; 66(3):290-7); PMID: 19798725.
  23. Cideciyan AV, Hauswirth WW, Aleman TS, Kaushal S, Schwartz SB, Boye SL, Windsor EA, Conlon TJ, Sumaroka A, Pang JJ, Roman AJ, Byrne BJ, Jacobson SG. Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year. Hum Gene Ther. 2009 Sep;20(9):999-1004. PMCID:PMC2829287
  24. Mah CS, Falk DJ, Germain SA, Kelley JS, Lewis MA, Cloutier DA, Deruisseau LR, Conlon TJ, Cresawn KO, Fraites Jr TJ, Campbell-Thompson M, Fuller DD, Byrne BJ. Gel-mediated Delivery of AAV1 Vectors Corrects Ventilatory Function in Pompe Mice with Established Disease. Mol Ther. 2010 Jan 26. PMCID:PMC2839425
  25. Lock M, McGorray S, Auricchio A, Ayuso E, Beecham EJ, Blouin-Tavel V, Bosch F, Bose M, Byrne BJ, Caton T, Chiorini JA, Chtarto A, Clark KR, Conlon T, Darmon C, Doria M, Douar A, Flotte TR, Francis JD, Francois A, Giacca M, Korn MT, Korytov I, Leon X, Leuchs B, Lux G, Melas C, Mizukami H, Moullier P, Müller M, Ozawa K, Philipsberg T, Poulard K, Raupp C, Rivière C, Roosendaal SD, Samulski RJ, Soltys SM, Surosky R, Tenenbaum L, Thomas DL, van Montfort B, Veres G, Wright JF, Xu Y, Zelenaia O, Zentilin L, Snyder RO. Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material. Hum Gene Ther. 2010 Oct;21(10):1273-85. PMCID:PMC2957240
  26. Weinstein DA, Correia CE, Conlon T, Specht A, Verstegen J, Onclin-Verstegen K, Campbell-Thompson M, Dhaliwal G, Mirian L, Cossette H, Falk D, Germain S, Clement N, Porvasnik S, Fiske L, Struck M, Ramirez HE, Jordan J, Andrutis K, Chou JY, Byrne B, Mah C. AAV-Mediated Correction of a Canine Model of Glycogen Storage Disease Type IA. Hum Gene Ther. 2010 Jul;21(7):903-10. PMCID:PMC2938360
  27. Mendell JR, Rodino-Klapac LR, Rosales XQ, Coley BD, Galloway G, Lewis S, Malik V, Shilling C, Byrne BJ, Conlon T, Campbell KJ, Bremer WG, Taylor LE, Flanigan KM, Gastier-Foster JM, Astbury C, Kota J, Sahenk Z, Walker CM, Clark KR. Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D. Ann Neurol. 2010 Nov;68(5):629-38. PMCID:PMC2970162
  28. Silver JN, Elder M, Flotte TR, Srivastava A, Cruz PE, Conlon T, Wright AJ. Recombinant AAV-Mediated Gene Transfer for the Potential Therapy of Adenosine Deaminase Deficient Severe Combined Immune Deficiency. Hum Gene Ther. 2011 Aug;22(8):935-49. PMID: 21142972.
  29. Andrew Specht, Laurie Fiske, Kirsten Erger, Travis Cossette, John Verstegen, Martha Campbell-Thompson, Maggie B. Struck, Young Mok Lee, Janice Y. Chou, Barry J. Byrne, Catherine E. Correia, Cathryn S. Mah, David A. Weinstein, and Thomas J. Conlon. Glycogen storage disease type Ia in canines: A model for human metabolic and genetic liver disease. J Biomed Biotechnol. 2011;2011:646257.Review. PMCID:PMC3027000
  30. Barry J. Byrne, Darin J. Falk, Christina A. Pacak, Sushrusha Nayak, Roland W. Herzog, Melissa E. Elder, Shelley W. Collins, Thomas J. Conlon, Nathalie Clement, Brian D. Cleaver, Denise A. Cloutier, Stacy L. Porvasnik, Saleem Islam, Mai K. Elmallah, Anatole Martin, Barbara K. Smith, David D. Fuller, Lee Ann Lawson and Cathryn S. Mah. Pompe Disease Gene Therapy. Hum Mol Genet. 2011 Apr 15;20(R1):R61-8; PMCID:PMC3095055
  31. Sanford L. Boye, Thomas Conlon, Kirsten Erger, Renee Ryals, Andy Neeley, Travis Cossette, Jijing Pang, Frank M. Dyka, William W. Hauswirth, Shannon E. Boye. Long term preservation of cone photoreceptors and restoration of cone function by gene therapy in the guanylate cyclase-1 knockout (GC1KO) mouse. Invest Ophthalmol Vis Sci. 2011 Sep 9;52(10):7098-108.PMCID: PMC3207713
  32. Jacobson SG, Cideciyan AV, Ratnakaram R, Heon E, Schwartz SB, Roman AJ, Peden MC, Aleman TS, Boye SL, Sumaroka A, Conlon TJ, Calcedo R, Pang JJ, Erger KE, Olivares MB, Mullins CL, Swider M, Kaushal S, Feuer WJ, Iannaccone A, Fishman GA, Stone EM, Byrne BJ, Hauswirth WW. Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years. Arch Ophthalmol. 2012 Jan;130(1):9-24. PMID: 21911650
  33. Polyak S, Mach A, Porvasnik S, Dixon L, Conlon T, Erger KE, Acosta A, Wright AJ, Campbell-Thompson M, Zolotukhin I, Wasserfall C, Mah C.Identification of adeno-associated viral vectors suitable for intestinal gene delivery and modulation of experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2012 Feb 1;302(3):G296-308. PMID: 22114116
  34. Keeler AM, Conlon T, Walter G, Zeng H, Shaffer SA, Dungtao F, Erger K, Cossette T, Tang Q, Mueller C, Flotte TR. Long-term Correction of Very Long-chain Acyl-CoA Dehydrogenase Deficiency in Mice Using AAV9 Gene Therapy. Mol Ther. 2012 Jun;20(6):1131-8. PMCID:PMC3370259
  35. Lee NC, Falk DJ, Byrne BJ, Conlon TJ, Clement N, Porvasnik S, Jorgensen ML, Potter M, Erger KE, Watson R, Ghivizzani S, Chiu HC, Chien YH, Hwu WL. An acidic oligopeptide displayed on AAV2 improves axial muscle tropism after systemic delivery. Genet Vaccines Ther. 2012 Jun 18;10(1):3. PMID:22709483
  36. Elmallah MK, Falk D, Lane MA, Lee KZ, Conlon TJ, Shafi NI, Reier PJ, Byrne B, Fuller DD. Retrograde gene delivery to hypoglossal motoneurons using AAV9. Hum Gene Ther Methods. Hum Gene Ther Methods. 2012 Apr;23(2):148-56. PMID:22746171
  37. Boye SE, Alexander JJ, Boye SL, Witherspoon CD, Sandefer KJ, Conlon TJ, Erger K, Sun J, Ryals R, Chiodo VA, Clark ME, Girkin CA, Hauswirth WW, Gamlin PD. The human rhodopsin kinase promoter in an AAV5 vector confers rod- and cone-specific expression in the primate retina. Hum Gene Ther. 2012 Oct;23(10):1101-15. PMID: 22845794

Abstracts

* = Presented by grad student or medical student

  1. Sosa I, DVM, University of Florida; Winter MD, DVM, DACVR, University of Florida; Erger K, MBA, University of Florida; Mincey B, BS, University of Florida; Shih A, DVM; DACVA; Conlon TJ, PhD, University of Florida; Estrada AH, DVM, ACVIM (Cardiology), University of Florida. Biodistribution of retrograde coronary sinus delivery of mesenchymal stem cells: a pilot study. NAVRMA 2012.
  2. *Allison M. Keeler, Thomas Conlon, Kirsten Erger, Scott Shaffer, Terence R. Flotte. Sex-Dependent Expression of Very Long Chain acyl-CoA Dehydrogenase (VLCAD) Transgene and the Role of the Liver in biochemical and Phenotypic Correction of VLCAD Deficiency. ASGCT 2012.
  3. *Allison M. Keeler, Miguel Sena-Esteves, Thomas Conlon, Kirsten Erger, Fu Dongtao, Terence R. Flotte. Transduction and Expression in brain after Systemic Delivery of Single Stranded AAV9 in Adult Mice. ASGCT 2012.
  4. Shipla Prabhakar, Mehran Taherian, David Gianni, Thomas J. Conlon, Anat S. Rachamimov, Miguel S. Esteves, Xandra O. Breakefield, Gary J. Brenner. Regression of Schwannomas Induced by AAV-Mediated Delivery of Caspase-1. ASGCT 2012.
  5. *Darin J. Falk, Cathryn S. Mah, Meghan S. Soustek, Kun-Ze Lee, Denise A. Cloutier, Mai K. Elmallah, Kirsten E. Erger, Thomas J. Conlon, David D. Fuller, Barry J. Byrne. Intrathoracic Administration of AAV9 Reverses Neural and Cardiorespiratory Dysfunction in Pompe Disease. ASGCT 2011. Seattle, Washington.
  6. Sanford L. Boye, Thomas Conlon, Kirsten Erger, Travis Cossette, Jijing Pang, Sukanya Karan, Renee Ryals, Wolfgang Baehr, William W. Hauswirth, Shannon E. Boye. Long-Term Persistence of AAV Mediated Gene Therapy for Leber Congenital Amaurosis Type 1 (LCA1). ASGCT 2011.
  7. *Allison M. Keeler, Glenn Walters, Thomas Conlon, Karin Green, Christian Mueller, Terence R. Flotte. Long-Term Correction of Very Long-Chain Acyl-CoA Deydrogenase Deficiency by Recombinant Adeno-Associated Virus 9 Gene Therapy. ASGCT 2011. Seattle, Washington.
  8. Shannon E. Boye, Sanford L. Boye, Thomas Conlon, Kristin Erger, Jijing Pang, Xuan Liu, Sukanya Karan, Wolfgang Baehr, William W. Hauswirth. Gene Therapy for Gucy2d Leber congenital amaurosis (LCA1). ARVO 2011. Fort Lauderdale, Florida.
  9. A Specht, L Fiske, K Erger, T Cossette, A Thomas, J Verstegen, M Campbell-Thompson, MB Struck, BJ Byrne, CE Correia, CS Mah, DA Weinstein, TJ Conlon. Clinical Manifestations of Heterozygous Expression of a Mutation that Causes Glycogen Storage Disease Type IA in Dogs. ACVIM 2011. Denver, Colorado.
  10. Polyak S, Conlon T, Mach A, Porvasnik S, Wasserfall C, Dixon L, Mah C. Intestinal Directed Adeno-associated Virus Expressing IL-10 Improves Enterocolitis in a Murine Model of Inflammatory Bowel Disease. Digestive Disease Week AGA Meeting, New Orleans, LA 2010
  11. *Kirsten Erger, Stacy Porvasnik, Travis Cossette, Lynn Combee, Cheryl Roberts, Corinne Abernathy, Carol Detrisac, Thomas Conlon, Barry Byrne. Preclinical Toxicology and Biodistribution Study of Recombinant Adeno-associated Virus 1 (rAVV1) Human Acid a-Glucosidase (GAA) in NZW Rabbits by Intrathoracic Direct Injection in the Diaphragm. American Society of Gene Therapy 2009. San Diego, California.
  12. Mark L. Brantly, Margaret Humphries, Sihong Song, Thomas Conlon, Amy Poirier, Barry J. Byrne, Richard Snyder, Terence R. Flotte. Phase I Clinical Trial of Recombinant Adeno-Associated Virus (rAAV)-Alpha-1 Antitrypsin Vectors. Molecular Therapy 2005. American Society of Gene Therapy 2005. St. Louis, Missouri.
  13. Amy E. Poirier, Thomas J. Conlon, Lynn A. Combee, Kirsten E. Erger, Terence R. Flotte. Toxicology and Biodistribution Studies of a Recombinant Adeno-Associated Virus 1 (rAAV1) Alpha-1 Antitrypsin (AAT) Vector. Molecular Therapy 2005. American Society of Gene Therapy 2005. St. Louis, Missouri.
  14. Kirsten E. Erger, Thomas J. Conlon, Travis L. Cossette, Thomas A. Bobik, Terence R. Flotte. In Vivo Expression of Human Cob(I)alamin Adenosyltransferase Using rAAV Serotypes 1,2 and 8, an Approach to Gene Therapy for Methylmalonic Aciduria (MMA). Molecular Therapy 2005. American Society of Gene Therapy 2005. St. Louis, Missouri.
  15. Brantly M, Humphries M, Song S, Conlon T, Poirier A, Byrne BJ, Snyder R and Flotte TR. Prelinical and Phase I/II Clinical Trials of Recombinant Adeno-Associated Virus (rAAV)-Alpha-1 Antitrypsin Vectors. 2005 Pediatric Academic Societies annual meeting. Washington, DC.

University of Florida Poster Presentations

  1. Wei F, Song S, Loiler S, Cruz P, Conlon T, Wei J, Zhao G, Flotte T. Recombinant Adeno-Associated Virus-Mediated Gene Transfer for Embryonic Stem Cell Gene Therapy. Pediatric Research Day 2003; 53:256A. Gainesville, Florida.
  2. Virella-Lowell I, Zuzman B, Conlon T, Morgan M, Song S, Flotte TR. A CMV/beta actin hybrid promoter improves rAAV vector expression in vitro and in vivo. Pediatric Research Day 2000; 47:483A. Gainesville, Florida.
  3. Conlon TJ, Brantly M, Lewin A, Flotte TR. A ribozyme-mediated gene therapy approach for neonatal liver disease due to PIZ mutant alpha 1-antitrypsin. Pediatric Research Day 2000; 47:239A. Gainesville, Florida.
  4. Thomas Conlon, Amara Estrada, Bijoy Thattaliyath, Stacy Porvasnik, Andre Shih, Travis Cossette, Sean Germain, Barry Byrne. Modified Skeletal Myoblast Therapy for Cardiac Failure Using AAV SDF1 in Rattus and Porcine Models. University of Florida Pediatrics Science Days. May 13, 2010.
  5. Thomas Conlon, Amara Estrada, Bijoy Thattaliyath, Stacy Porvasnik, Andre Shih, Travis Cossette, Sean Germain, Barry Byrne. Modified Skeletal Myoblast Therapy for Cardiac Failure Using AAV SDF1 in Rattus and Porcine Models. University of Florida College of Medicine Celebration of Research. April 19, 2010.
  6. Kirsten Erger, Stacy Porvasnik, Travis Cossette, Lynn Combee, Cheryl Roberts, Corinne Abernathy, Carol Detrisac, Thomas Conlon, Barry Byrne. Preclinical Toxicology and Biodistribution Study of Recombinant Adeno-associated Virus 1 (rAVV1) Human Acid a-Glucosidase (GAA) in NZW Rabbits by Intrathoracic Direct Injection in the Diaphragm. University of Florida Pediatrics Science Day, April 24th, 2009.
  7. Kirsten Erger, Lynn A Combee, Travis Cossette, Cheryl Roberts, Stacy Porvasnik, Denise Cloutier, Thomas J Conlon, Barry J Byrne. Toxicology, Biodistribution and Long Term Safety Study of a Recombinant AAV1 Vector for Limb Girdle Muscular Dystrophy (LGMD) TYPE-2D. University of Florida Pediatrics Science Day, March 13th, 2008.
  8. LM Fiske*, A Specht*, K Erger, T Cossette, A Thomas, J Verstegen, M Campbell-Thompson, MB Struck, BJ Byrne, CE Correia, CS Mah, TJ Conlon**, DA Weinstein** Evidence of Abnormal Growth and Metabolic Profiles in Heterozygotes in the Canine Model of Glycogen Storage Disease Type Ia. University of Florida Pediatrics Science Day, March 5th, 2012.

Poster Presentations

  1. Poirier A, Combee L, Martino A, Conlon T, and Flotte TR. Toxicology and biodistribution of AAV-AAT vectors. Presented at the American Society of Gene Therapy meeting, Minneapolis, MN, June 2-6, 2004.
  2. Poirier A, Combee L and Flotte TR. Toxicology and biodistribution of AAV-AAT vectors. Presented at the American College of Toxicology meeting, November 2-5, 2004, Washington D.C.
  3. Poirier AE, Conlon TJ, Combee LA, Erger KE, Flotte TR. Presented at the American Society of Gene Therapy conference, St. Louis, MO, June 1-5, 2005.

University of Florida Lecture

  1. Proof of Concept, Preclinical and Phase I Clinical Trials of rAAV-AAT. University of Florida Department of Pediatrics Bench to Bedside and Beyond. Jun 3, 2009.